UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 112

Sortiert nach

Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers

Molecular cancer research, 2018-05, Vol.16 (5), p.805-812

2018

Link zum Volltext

Verfügbarkeit prüfen

A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer

Cancer, 2018-06, Vol.124 (11), p.2337-2346

2018

Link zum Volltext

Verfügbarkeit prüfen

Landscape of KRAS G12C , Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS -Mutated Cancers

JCO precision oncology, 2022-05, Vol.6, p.e2100245

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of KRAS mutation variants on clinicopathological features and outcomes in patients with metastatic pancreatic adenocarcinoma

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.749-749

2023

Link zum Volltext

Verfügbarkeit prüfen

Maintenance therapy with capecitabine in patients with resected pancreatic adenocarcinoma after adjuvant therapy: a retrospective cohort study

Gastrointestinal cancer research, 2014-05, Vol.7 (3-4), p.91-97

2014

Link zum Volltext

Verfügbarkeit prüfen

The prevalence of common KRAS variants and associated outcomes in patients with metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.173-173

2022

Link zum Volltext

Verfügbarkeit prüfen

Irinotecan and 5-FU/ leucovorin in metastatic colorectal cancer: balancing efficacy, toxicity, and logistics

Oncology (Williston Park, N.Y.), 2004-12, Vol.18 (14 Suppl 14), p.26

Hwang, Jimmy J

2004

Link zum Volltext

Verfügbarkeit prüfen

Predictors of early mortality in early and late onset pancreatic cancer (PC)

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.543-543

2022

Link zum Volltext

Verfügbarkeit prüfen

Utilization of germline testing in patients with early-onset pancreatic cancer (EOPC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16300-e16300

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of fluorouracil (FU), leucovorin (LV), and nanoliposomal irinotecan (nal-IRI) in previously treated advanced biliary tract cancer (NAPOLI-2)

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.TPS593-TPS593

2020

Link zum Volltext

Verfügbarkeit prüfen

A phase I, open-label, dose-escalation trial of BI 1701963 as monotherapy and in combination with trametinib in patients with KRAS mutated advanced or metastatic solid tumors

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS3651-TPS3651

2020

Link zum Volltext

Verfügbarkeit prüfen

Low Overexpression of HER-2 Neu in Advanced Colorectal Cancer Limits the Usefulness of Trastuzumab (Herceptin®) and Irinotecan as Therapy. A Phase II Trial

Cancer investigation, 2004, Vol.22 (6), p.858-865

2004

Link zum Volltext

Verfügbarkeit prüfen

Impact of preoperative chemoradiotherapy (CRT) on the rectal tumor microenvironment (TME) and associated patient outcomes

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.157-157

2022

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab plus ipilimumab (N+I) in patients (pts) with colorectal cancer (CRC) with high tumor mutational burden (hTMB): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.107-107

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-world experience of an in-house dihydropyrimidine dehydrogenase ( DPYD ) genotype test to guide fluoropyrimidine (FP) dosing at a multisite cancer hospital

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1534-1534

2023

Link zum Volltext

Verfügbarkeit prüfen

The role of gene expression of CDC37 in colorectal cancer (CRC)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.237-237

2023

Link zum Volltext

Verfügbarkeit prüfen

The role of gene expression of CD47 in colorectal cancer (CRC)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.240-240

2023

Link zum Volltext

Verfügbarkeit prüfen

Landscape of KRAS G12C , associated genomic alterations, and interrelation with immuno-oncology (IO) biomarkers

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3127-3127

2021

Link zum Volltext

Verfügbarkeit prüfen

Landscape of endocytosis pathway in colorectal cancer (CRC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3148-3148

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of socioeconomic status (SES) on colorectal cancer patient survival: An analysis of 890,867 patients in the National Cancer Database (NCDB)

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.19-19

2021

Link zum Volltext

Verfügbarkeit prüfen

Socioeconomic status (SES) and survival outcomes in patients with gastrointestinal (GI) cancers: An analysis of 1.4 million patients in the National Cancer Database (NCDB)

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.458-458

2021

Link zum Volltext

Verfügbarkeit prüfen

Enrichment of alterations in targetable molecular pathways in KRAS wild-type (WT) pancreatic cancer (PC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4629-4629

2020

Link zum Volltext

Verfügbarkeit prüfen

Nintedanib in metastatic appendiceal carcinoma

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.TPS723-TPS723

2019

Link zum Volltext

Verfügbarkeit prüfen

Characterization of sociodemographic and clinicopathological features and associated outcomes of patients (Pts) with anal squamous cell cancer (ASCC): Analysis of 44,084 pts in the National Cancer Database (NCDB)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4052-4052

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 112

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(111)
Bücher
(1)

Sprache

Englisch
(112)
Japanisch
(3)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers

A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer

Landscape of KRAS G12C , Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS -Mutated Cancers

Impact of KRAS mutation variants on clinicopathological features and outcomes in patients with metastatic pancreatic adenocarcinoma

Maintenance therapy with capecitabine in patients with resected pancreatic adenocarcinoma after adjuvant therapy: a retrospective cohort study

The prevalence of common KRAS variants and associated outcomes in patients with metastatic colorectal cancer (mCRC)

Irinotecan and 5-FU/ leucovorin in metastatic colorectal cancer: balancing efficacy, toxicity, and logistics

Predictors of early mortality in early and late onset pancreatic cancer (PC)

Utilization of germline testing in patients with early-onset pancreatic cancer (EOPC)

Phase II study of fluorouracil (FU), leucovorin (LV), and nanoliposomal irinotecan (nal-IRI) in previously treated advanced biliary tract cancer (NAPOLI-2)

A phase I, open-label, dose-escalation trial of BI 1701963 as monotherapy and in combination with trametinib in patients with KRAS mutated advanced or metastatic solid tumors

Low Overexpression of HER-2 Neu in Advanced Colorectal Cancer Limits the Usefulness of Trastuzumab (Herceptin®) and Irinotecan as Therapy. A Phase II Trial

Impact of preoperative chemoradiotherapy (CRT) on the rectal tumor microenvironment (TME) and associated patient outcomes

Nivolumab plus ipilimumab (N+I) in patients (pts) with colorectal cancer (CRC) with high tumor mutational burden (hTMB): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study

Real-world experience of an in-house dihydropyrimidine dehydrogenase ( DPYD ) genotype test to guide fluoropyrimidine (FP) dosing at a multisite cancer hospital

The role of gene expression of CDC37 in colorectal cancer (CRC)

The role of gene expression of CD47 in colorectal cancer (CRC)

Landscape of KRAS G12C , associated genomic alterations, and interrelation with immuno-oncology (IO) biomarkers

Pertuzumab plus trastuzumab (P+T) in patients (pts) with biliary tract cancer (BTC) with ERBB2/3 amplification (amp), overexpression (oe), or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study

Landscape of endocytosis pathway in colorectal cancer (CRC)

Impact of socioeconomic status (SES) on colorectal cancer patient survival: An analysis of 890,867 patients in the National Cancer Database (NCDB)

Socioeconomic status (SES) and survival outcomes in patients with gastrointestinal (GI) cancers: An analysis of 1.4 million patients in the National Cancer Database (NCDB)

Enrichment of alterations in targetable molecular pathways in KRAS wild-type (WT) pancreatic cancer (PC)

Nintedanib in metastatic appendiceal carcinoma

Characterization of sociodemographic and clinicopathological features and associated outcomes of patients (Pts) with anal squamous cell cancer (ASCC): Analysis of 44,084 pts in the National Cancer Database (NCDB)

Aktive Filter

Suchergebnisse filtern